These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 16250661

  • 21. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
    Zhang MR, Haradahira T, Maeda J, Okauchi T, Kawabe K, Noguchi J, Kida T, Suzuki K, Suhara T.
    Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
    Kumar JS, Majo VJ, Hsiung SC, Millak MS, Liu KP, Tamir H, Prabhakaran J, Simpson NR, Van Heertum RL, Mann JJ, Parsey RV.
    J Med Chem; 2006 Jan 12; 49(1):125-34. PubMed ID: 16392798
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and Evaluation of 18F-Labeled Phenylpiperazine-like Dopamine D3 Receptor Radioligands for Positron Emission Tomography Imaging.
    Zhang G, Zhao S, Zhao Z, Jia C, Zhang Y, Xue J, Liu Y, Yang W.
    ACS Chem Neurosci; 2024 Oct 02; 15(19):3459-3472. PubMed ID: 39276340
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey.
    Liow JS, Morse CL, Lu S, Frankland M, Tye GL, Zoghbi SS, Gladding RL, Shaik AB, Innis RB, Newman AH, Pike VW.
    Molecules; 2018 Oct 23; 23(11):. PubMed ID: 30360553
    [Abstract] [Full Text] [Related]

  • 29. Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligands.
    Jean M, Renault J, Levoin N, Danvy D, Calmels T, Berrebi-Bertrand I, Robert P, Schwartz JC, Lecomte JM, Uriac P, Capet M.
    Bioorg Med Chem Lett; 2010 Sep 15; 20(18):5376-9. PubMed ID: 20708933
    [Abstract] [Full Text] [Related]

  • 30. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
    Shimoda Y, Yui J, Xie L, Fujinaga M, Yamasaki T, Ogawa M, Nengaki N, Kumata K, Hatori A, Kawamura K, Zhang MR.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5316-22. PubMed ID: 23830697
    [Abstract] [Full Text] [Related]

  • 31. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA, McCormick P, Kapur S, Willeit M, Garcia A, Hussey D, Houle S, Seeman P, Ginovart N.
    J Med Chem; 2005 Jun 16; 48(12):4153-60. PubMed ID: 15943487
    [Abstract] [Full Text] [Related]

  • 32. Labeling of benzodioxin piperazines with fluorine-18 as prospective radioligands for selective imaging of dopamine D4 receptors.
    Kügler F, Ermert J, Coenen HH.
    J Labelled Comp Radiopharm; 2013 Oct 16; 56(12):609-18. PubMed ID: 24285237
    [Abstract] [Full Text] [Related]

  • 33. Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor.
    Hocke C, Cumming P, Maschauer S, Kuwert T, Gmeiner P, Prante O.
    Nucl Med Biol; 2014 Mar 16; 41(3):223-8. PubMed ID: 24480780
    [Abstract] [Full Text] [Related]

  • 34. A series of 18F-labelled pyridinylphenyl amides as subtype-selective radioligands for the dopamine D3 receptor.
    Hocke C, Maschauer S, Hübner H, Löber S, Utz W, Kuwert T, Gmeiner P, Prante O.
    ChemMedChem; 2010 Jun 07; 5(6):941-8. PubMed ID: 20408162
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.
    Kügler F, Sihver W, Ermert J, Hübner H, Gmeiner P, Prante O, Coenen HH.
    J Med Chem; 2011 Dec 22; 54(24):8343-52. PubMed ID: 22039961
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J.
    J Nucl Med; 2006 Oct 22; 47(10):1697-706. PubMed ID: 17015907
    [Abstract] [Full Text] [Related]

  • 37. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E, Helin S, Marjamäki P, Grönroos T, Holm P, Löyttyniemi E, Någren K, Scheinin M, Haaparanta-Solin M, Sallinen J, Solin O.
    J Nucl Med; 2014 Jul 22; 55(7):1171-7. PubMed ID: 24799619
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors.
    Liu F, Majo VJ, Prabhakaran J, Milak MS, John Mann J, Parsey RV, Kumar JS.
    Bioorg Med Chem; 2011 Sep 01; 19(17):5255-9. PubMed ID: 21821420
    [Abstract] [Full Text] [Related]

  • 39. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.
    Hocke C, Prante O, Salama I, Hübner H, Löber S, Kuwert T, Gmeiner P.
    ChemMedChem; 2008 May 01; 3(5):788-93. PubMed ID: 18306190
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.